Home › Breast Cancer › Minnesota › Saint Paul
Breast Cancer clinical trials in Saint Paul, MN
12 studies for Breast Cancer are looking for participants at sites in and around Saint Paul (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi away
- and 3 more
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
- Health Partners Cancer Center at Regions Hospital, Saint Paul
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RecruitingPhase 3
- Research Site, Saint Paul
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RecruitingPhase 3
- Healthpartners Regions Specialty Clinics, Saint Paul
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
RecruitingPhase 1/2
- Metro-Minnesota Community Oncology Research Consortium, Saint Paul
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi away
- and 3 more
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Minnesota Oncology Hematology, Maplewood · 5 mi away
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RecruitingPhase 3
- Minnesota Oncology Hematology, P.A., Maplewood · 5 mi away
- Minnesota Oncology Hematology, P.A., Woodbury · 7 mi away
Axelopran for Advanced Cancer in Patients Receiving Opioids
RecruitingPhase 2
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecruitingPhase 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi away
- and 2 more
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi away
- and 3 more
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RecruitingPhase 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi away
- and 1 more
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA111 studies
- Nashville, TN80 studies
- Los Angeles, CA72 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Saint Paul
- Non-Small Cell Lung Cancer18 studies
- Lung Cancer13 studies
- Prostate Cancer13 studies
- Colorectal Cancer9 studies
- Ovarian Cancer8 studies
- Metastatic Cancer7 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Endometrial Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Melanoma6 studies
- Acute Myeloid Leukemia6 studies
- Obesity6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.